Metisazone
WikiDoc Resources for Metisazone |
Articles |
---|
Most recent articles on Metisazone |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Metisazone at Clinical Trials.gov Clinical Trials on Metisazone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Metisazone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Metisazone Discussion groups on Metisazone Patient Handouts on Metisazone Directions to Hospitals Treating Metisazone Risk calculators and risk factors for Metisazone
|
Healthcare Provider Resources |
Causes & Risk Factors for Metisazone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Methisazone (USAN) or metisazone (INN) is an antiviral drug that works by inhibiting mRNA and protein synthesis, especially in pox viruses. It has been used in the past to treat smallpox.[1]
Methisazone has been described as being used in prophylaxis since at least 1965.[2][3]
References
- ↑ Methisazone, Merriam-Webster's Medical Dictionary
- ↑ do Valle, LA; de Melo, PR; de Gomes, LF; Proença, LM (13 Nov 1965). "Methisazone in prevention of variola minor among contacts". Lancet. 2 (7420): 976–8. PMID 4159212.
- ↑ Weiss MM, Weiss PD, Mathisen G, Guze P (December 2004). "Rethinking smallpox". Clin. Infect. Dis. 39 (11): 1668–73. doi:10.1086/425745. PMID 15578369.